Back to results
CompletedPhase 2

Repeated-Dose Oral N-acetylcysteine for the Treatment of Parkinson's Disease

NCT02212678

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Primary location

University of Minnesota

Minneapolis, Minnesota, United States

View on ClinicalTrials.gov
Repeated-Dose Oral N-acetylcysteine for the Treatment of Parkinson's Disease — TrialFind